Proton Sensitivity of Corticotropin-Releasing Hormone Receptor 1 Signaling to Proopiomelanocortin in Male Mice.


Journal

Endocrinology
ISSN: 1945-7170
Titre abrégé: Endocrinology
Pays: United States
ID NLM: 0375040

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 28 10 2018
accepted: 03 12 2018
pubmed: 12 12 2018
medline: 4 12 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Because an acidic cellular microenvironment is engendered by inflammation and may determine cell differentiation, we elucidated the impact of acidic conditions on induction of proopiomelanocortin (POMC) expression. Here, we demonstrate mechanisms for proton sensitivity of CRH receptor 1 (CRHR1) signaling to POMC and ACTH production. Low pH (6.8) resulted in doubling of POMC expression and ACTH production in pituitary cell line AtT-20 and in primary mouse pituitary cells. Using CRISPR knockout, we show that CRHR1 is necessary for acid-induced POMC expression, and this induction is mediated by CRHR1 histidine residues and calmodulin-dependent protein kinase II in both pituitary corticotroph cells and in nonpituitary cell lines expressing ectopic ACTH. In contrast, CRH ligand binding affinity to CRHR1 was decreased with acidic pH, implying that proton-induced POMC expression prevails in acidic conditions independently of CRH ligand binding. The results indicate that proton-induced CRHR1 signaling regulates ACTH production in response to an acidic microenvironment.

Identifiants

pubmed: 30535142
pii: 5231486
doi: 10.1210/en.2018-00920
pmc: PMC6324021
doi:

Substances chimiques

Receptors, Corticotropin-Releasing Hormone 0
CRF receptor type 1 5CLY6W2H1M
Pro-Opiomelanocortin 66796-54-1
Adrenocorticotropic Hormone 9002-60-2
Calcium-Calmodulin-Dependent Protein Kinase Type 2 EC 2.7.11.17

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

276-291

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK113998
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007770
Pays : United States

Références

Am J Physiol. 1983 May;244(5):E453-8
pubmed: 6303130
Nature. 2003 Sep 4;425(6953):93-8
pubmed: 12955148
Am J Physiol. 1989 Aug;257(2 Pt 2):R344-9
pubmed: 2548408
Am J Physiol. 1993 Feb;264(2 Pt 2):R324-30
pubmed: 8383463
Psychiatry Res. 1987 May;21(1):23-32
pubmed: 3037579
J Leukoc Biol. 2001 Apr;69(4):522-30
pubmed: 11310837
Protein Cell. 2013 Oct;4(10):747-60
pubmed: 24057762
J Endocrinol. 2007 May;193(2):279-90
pubmed: 17470519
Nucleic Acids Res. 2016 Jul 8;44(W1):W272-6
pubmed: 27185894
J Biol Chem. 2000 Feb 4;275(5):3121-7
pubmed: 10652295
Am Rev Respir Dis. 1986 Mar;133(3):396-9
pubmed: 3006560
Front Physiol. 2013 Dec 17;4:370
pubmed: 24381558
J Leukoc Biol. 1998 Jun;63(6):740-5
pubmed: 9620667
Proc Soc Exp Biol Med. 1999 Feb;220(2):100-5
pubmed: 9933504
Int J Cancer. 2017 Jun 1;140(11):2517-2525
pubmed: 28214331
J Phys Chem B. 2015 Feb 19;119(7):2806-17
pubmed: 25607803
Nat Rev Cancer. 2017 Oct;17(10):577-593
pubmed: 28912578
Cell Tissue Res. 2014 Nov;358(2):515-25
pubmed: 25129106
J Clin Endocrinol Metab. 2012 Oct;97(10):E1851-61
pubmed: 22869609
J Mol Biol. 2000 Sep 8;302(1):205-17
pubmed: 10964570
Atherosclerosis. 2002 Sep;164(1):27-35
pubmed: 12119190
J Biol Chem. 2008 Dec 19;283(51):35644-51
pubmed: 18955489
Cell. 2001 Mar 23;104(6):849-59
pubmed: 11290323
Oncotarget. 2015 May 20;6(14):11725-34
pubmed: 25961153
Cell Signal. 2013 Nov;25(11):2263-71
pubmed: 23917207
Cancer Res. 2016 Mar 15;76(6):1381-90
pubmed: 26719539
J Clin Invest. 2011 Dec;121(12):4712-21
pubmed: 22105169
J Neurosci Res. 2015 Jul;93(7):1045-55
pubmed: 25881750
Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):694-9
pubmed: 10712309
Endocr Relat Cancer. 2016 Nov;23(11):857-870
pubmed: 27935805
J Mol Endocrinol. 2016 May;56(4):T99-T112
pubmed: 26792828
J Mol Biol. 2001 Jan 19;305(3):567-80
pubmed: 11152613
Endocrinology. 1976 Oct;99(4):1071-9
pubmed: 185045
J Neuroendocrinol. 2008 Jun;20(6):692-9
pubmed: 18601691
Handb Exp Pharmacol. 2009;(194):283-332
pubmed: 19655111
Arthritis Rheum. 1971 Jul-Aug;14(4):475-84
pubmed: 5564921
Science. 1984 May 4;224(4648):452-9
pubmed: 6143403
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8967-71
pubmed: 7692441
PLoS Biol. 2011 Jul;9(7):e1001112
pubmed: 21814490
Biochem Biophys Res Commun. 1983 Jan 27;110(2):602-8
pubmed: 6301458
Neuroendocrinology. 2011;94(1):12-20
pubmed: 21576930
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Am J Physiol. 1988 Mar;254(3 Pt 2):R431-5
pubmed: 2831742
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5211-6
pubmed: 23479653
Tumour Biol. 2015 Mar;36(3):1811-7
pubmed: 25377161
Bioinformatics. 2014 Mar 15;30(6):884-6
pubmed: 24162465
Proc Soc Exp Biol Med. 1997 Feb;214(2):156-60
pubmed: 9034133
Neuroendocrinology. 1992 Jul;56(1):112-7
pubmed: 1641069
J Immunol. 2014 Apr 15;192(8):3915-24
pubmed: 24634496
J Biol Chem. 2017 Jun 16;292(24):9865-9881
pubmed: 28356352
Mol Endocrinol. 2002 Jul;16(7):1638-51
pubmed: 12089357

Auteurs

Hiraku Kameda (H)

Pituitary Center, Cedars-Sinai Medical Center, Los Angeles, California.

Masaaki Yamamoto (M)

Pituitary Center, Cedars-Sinai Medical Center, Los Angeles, California.

Yukiko Tone (Y)

Research Division of Immunology, Pacific Heart Lung and Blood Institute, Los Angeles, California.

Masahide Tone (M)

Research Division of Immunology, Pacific Heart Lung and Blood Institute, Los Angeles, California.

Shlomo Melmed (S)

Pituitary Center, Cedars-Sinai Medical Center, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH